Best in Biotech 24 Jul 2025 Which biotech companies are gaining traction in genetic diseases? Discover twelve companies focused on genetic diseases that managed to close funding rounds in the last two years. July 24, 2025 - 12 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 23 Jul 2025 Biotech stars of 2024, did they shine or fade in 2025? Find out if the biotech companies Labiotech designated as the ones to keep an eye on in 2024 held up to our expectation in 2025. July 23, 2025 - 6 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 18 Jul 2025 Hyderabad’s Genome Valley, biopharma’s scale-up hub Discover how Genome Valley is emerging as an essential partner in global biopharma and how it is now venturing into cell and gene therapy. July 18, 2025 - 10 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Podcast 18 Jul 2025Taking the fight to inflammatory disease: InflaRx’s first-in-class C5a/C5aR signaling pathway strategy This week, I talked to Niels Riedemann, CEO and Founder of InflaRx, about his company’s first-in-class approach to fighting inflammation. July 18, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
News and Trends 10 Jul 2025 Radiopharma’s new wave: Nuclidium and Actithera raise the stakes Take a closer look at the radiopharma new wave as Nuclidium and Actithera raise big to develop their platforms. July 10, 2025 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 9 Jul 2025 New hope for CIPN: Can emerging therapies ease chemotherapy’s nerve damage? Delve into the growing field of CIPN, the most common side effect of chemotherapy, as we are getting closer to a first approval. July 9, 2025 - 6 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 4 Jul 2025 14 biotech companies to know in the Boston area in 2025 Explore Boston’s vibrant biotech landscape with fourteen innovative companies leading the charge in life sciences research. July 4, 2025 - 15 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 1 Jul 2025 Is an HIV cure possible? The future of HIV therapy Delve into the field of HIV treatment development. Since the virus was discovered, treatments have improved, but are we close to a cure? July 1, 2025 - 11 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Podcast 27 Jun 2025Humacyte: Saving lives with lab-grown blood vessels in conflict zones This week we spoke to Humacyte founder, Laura Niklason about the real-world applications for lab-grown blood vessels in conflict zones. June 27, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
News and Trends 23 Jun 2025 Turning plastic into medicine: Closing the loop on pharma production Find out about the University of Edinburgh’s work to convert our common plastic wast into the wildly used paracetamol. June 23, 2025 - 4 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 18 Jun 2025 From undruggable to oral therapy: The rise of STAT6 degraders Delve into the STAT6 degrader technology and what it could bring to inflammatory and allergic disease treatment. June 18, 2025 - 5 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 16 Jun 2025 Did Novo open the Canadian market to GLP-1 generics? Find out if Novo’s GLP-1 patent expiring in Canada is a mistake or a calculated move. Did the firm lose exclusivity over a small fee? June 16, 2025 - 8 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email